A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study

A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia

(2014) Peter J. Weiden et al.   SCHIZOPHRENIA RESEARCH

Role of α1 adrenergic antagonism in the mechanism of action of iloperidone: reducing extrapyramidal symptoms

(2013) Stephen M. Stahl   CNS SPECTRUMS

Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial

(2013) Andrew J. Cutler et al.   CNS SPECTRUMS

A Thorough QTc Study of 3 Doses of Iloperidone Including Metabolic Inhibition Via CYP2D6 and/or CYP3A4 and a Comparison to Quetiapine and Ziprasidone

(2012) Steven G. Potkin et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia

(2008) Andrew J. Cutler et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Long-Term Efficacy and Safety of Iloperidone

(2008) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Safety Profile of Iloperidone

(2008) Peter J. Weiden et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Efficacy of Iloperidone in the Treatment of Schizophrenia

(2008) Steven G. Potkin et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY